Related Experiment Videos
[Pathophysiology of congestive heart failure]
1Dipartimento Clinico Sperimentale di Medicina e Farmacologia, Sezione di Cardiologia, Università degli Studi, Messina, Italy.
Minerva Cardioangiologica
|July 11, 2002
Summary
Congestive heart failure (CHF) is increasingly understood as a neurohormonal disease. Targeting this neuroendocrine activation is key to reducing mortality in CHF patients.
Area of Science:
- Cardiology
- Endocrinology
- Immunology
Context:
- Congestive heart failure (CHF) pathophysiology has evolved significantly over the past 20 years.
- CHF is now recognized as a complex neurohormonal disease, not solely a cardiocirculatory issue.
- Abnormal neuroendocrine activation precedes clinical heart failure and drives disease progression.
Purpose:
- To analyze the role of neuroendocrine activation in the pathophysiology of congestive heart failure.
- To highlight the prognostic value of circulating neurohormonal factors in CHF.
- To discuss the impact of cytokines and apoptosis on CHF progression.
Summary:
- Neurohormonal activation plays a critical role in the progression of congestive heart failure.
- Elevated levels of certain neurohormonal factors are associated with a negative prognosis in CHF patients.
- Immunological factors like cytokines and apoptosis also contribute negatively to CHF pathophysiology.
Impact:
- Understanding neurohormonal mechanisms is crucial for developing effective CHF therapies.
- Therapeutic strategies targeting neurohormonal imbalances offer the most promising approach to decrease CHF mortality.
- This review synthesizes current knowledge on neuroendocrine activation in CHF pathophysiology.